Nano Labs Announces US$500 Million Convertible Notes Private Placement for BNB Treasury Strategy
Nano Labs (Nasdaq: NA) has announced a significant financial move, entering into a US$500 million convertible notes purchase agreement with several investors. The notes will mature in 360 days with no interest and are convertible into Class A ordinary shares at an initial price of US$20 per share.
This agreement is part of a larger strategic initiative where Nano Labs plans to acquire US$1 billion worth of BNB through convertible notes and private placements. The company's long-term goal is to hold 5% to 10% of BNB's total circulating supply.
Nano Labs (Nasdaq: NA) ha annunciato una mossa finanziaria significativa, stipulando un accordo per l'acquisto di note convertibili da 500 milioni di dollari con diversi investitori. Le note scadranno in 360 giorni senza interessi e sono convertibili in azioni ordinarie di Classe A a un prezzo iniziale di 20 dollari per azione.
Questo accordo fa parte di un'iniziativa strategica più ampia in cui Nano Labs intende acquisire BNB per un valore di 1 miliardo di dollari attraverso note convertibili e collocamenti privati. L'obiettivo a lungo termine dell'azienda è detenere dal 5% al 10% della fornitura totale in circolazione di BNB.
Nano Labs (Nasdaq: NA) ha anunciado un movimiento financiero importante, firmando un acuerdo de compra de pagarés convertibles por 500 millones de dólares con varios inversores. Los pagarés vencerán en 360 días sin intereses y son convertibles en acciones ordinarias Clase A a un precio inicial de 20 dólares por acción.
Este acuerdo forma parte de una iniciativa estratégica más amplia en la que Nano Labs planea adquirir BNB por un valor de 1.000 millones de dólares mediante pagarés convertibles y colocaciones privadas. El objetivo a largo plazo de la compañía es poseer entre el 5% y el 10% del suministro total circulante de BNB.
Nano Labs (Nasdaq: NA)는 여러 투자자들과 함께 5억 달러 규모의 전환사채 매입 계약을 체결하는 중요한 재무 조치를 발표했습니다. 전환사채는 360일 만기이며 이자가 없고, 초기 전환 가격은 주당 20달러인 클래스 A 보통주로 전환 가능합니다.
이번 계약은 Nano Labs가 전환사채와 사모 발행을 통해 10억 달러 상당의 BNB를 인수하려는 더 큰 전략적 계획의 일환입니다. 회사의 장기 목표는 BNB 전체 유통량의 5%에서 10%를 보유하는 것입니다.
Nano Labs (Nasdaq : NA) a annoncé une opération financière importante en concluant un accord d'achat d'obligations convertibles de 500 millions de dollars avec plusieurs investisseurs. Les obligations arriveront à échéance dans 360 jours sans intérêts et sont convertibles en actions ordinaires de classe A à un prix initial de 20 dollars par action.
Cette entente s'inscrit dans le cadre d'une initiative stratégique plus large où Nano Labs prévoit d'acquérir pour 1 milliard de dollars de BNB via des obligations convertibles et des placements privés. L'objectif à long terme de la société est de détenir entre 5 % et 10 % de l'offre totale en circulation de BNB.
Nano Labs (Nasdaq: NA) hat eine bedeutende finanzielle Maßnahme angekündigt und einen Kaufvertrag über wandelbare Schuldverschreibungen im Wert von 500 Millionen US-Dollar mit mehreren Investoren abgeschlossen. Die Schuldverschreibungen haben eine Laufzeit von 360 Tagen, sind zinsfrei und in Class-A-Stammaktien zu einem Anfangspreis von 20 US-Dollar pro Aktie wandelbar.
Diese Vereinbarung ist Teil einer größeren strategischen Initiative, bei der Nano Labs plant, BNB im Wert von 1 Milliarde US-Dollar durch Wandelanleihen und Privatplatzierungen zu erwerben. Das langfristige Ziel des Unternehmens ist es, 5 % bis 10 % des gesamten umlaufenden BNB-Angebots zu halten.
- Secured US$500 million in convertible notes financing
- No interest accruing on the notes, reducing financing costs
- Strategic plan to acquire US$1 billion worth of BNB
- Ambitious goal to hold 5-10% of BNB's total circulating supply
- Notes mature in just 360 days, creating short-term repayment pressure
- Potential dilution risk for shareholders if notes are converted
- No guarantee of closing, subject to customary conditions
- Significant exposure to BNB cryptocurrency price volatility
HONG KONG, June 24, 2025 (GLOBE NEWSWIRE) -- Nano Labs Ltd (Nasdaq: NA) ("we," the "Company" or "Nano Labs"), a leading Web 3.0 infrastructure and product solution provider in China, today announces that it has entered into a convertible notes purchase agreement (the “Agreement”) under which the Company has agreed to issue, and several investors have agreed to subscribe for, a convertible promissory notes in the aggregate principal amount of US
The Notes will mature in 360 days following the issuance, with no interest accruing on the outstanding principal amount. During 360 days from the date of this Notes, the Notes are convertible, in whole or in part, into the Class A ordinary shares of the Company (the “Ordinary Shares”) at the option of the holder thereof. The conversion price is initially US
The closing under the agreement is subject to customary closing conditions. There is no guarantee that closing will happen in full or at all. Investors should not place on due reliance on this press release.
The Agreement marks an important step in the Company’s strategic growth. As part of this initiative, Nano Labs will conduct a thorough assessment of the security and value of BNB. In the initial phase, the Company plans to acquire US
About Nano Labs Ltd
Nano Labs Ltd is a leading Web 3.0 infrastructure and product solution provider in China. Nano Labs is committed to the development of high throughput computing (“HTC”) chips and high performance computing (“HPC”) chips. Nano Labs has built a comprehensive flow processing unit (“FPU”) architecture which offers solution that integrates the features of both HTC and HPC. In addition, it has established Bitcoin value investment and adopted Bitcoin as primary reserve asset. Nano Labs has established an integrated solution platform covering three main business verticals, including HTC solutions and HPC solutions. The HTC solutions feature its proprietary Cuckoo series chips, which have become alternative Application-Specific Integrated Circuit (“ASIC”) solutions for traditional GPUs. Nano Lab’s Cuckoo series are one of the first near-memory HTC chips available in the market*. For more information, please visit the Company’s website at: ir.nano.cn.
*According to an industry report prepared by Frost & Sullivan.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements include, without limitation, the Company's plan to appeal the Staff's determination, which can be identified by terminology such as "may," "will," "expect," "anticipate," "aim," "estimate," "intend," "plan," "believe," "potential," "continue," "is/are likely to" or other similar expressions. Such statements are based upon management's current expectations and current market and operating conditions, and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and many of which are beyond the Company's control, which may cause the Company's actual results, performance or achievements to differ materially from those in the forward-looking statements. Further information regarding these and other risks, uncertainties or factors is included in the Company's filings with the Securities and Exchange Commission. The Company does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under law.
For investor and media inquiries, please contact:
Nano Labs Ltd
Email: ir@nano.cn
Ascent Investor Relations LLC
Tina Xiao
Phone: +1-646-932-7242
Email: investors@ascent-ir.com
